<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20110912007529N16</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2017-12-27</date_registration>
      <primary_sponsor>Vice chancellor for research, Shahed University</primary_sponsor>
      <public_title>Effects of acupressure therapy on patients weaning from mechanical ventilation</public_title>
      <acronym></acronym>
      <scientific_title>Effects of acupressure therapy on anxiety, agitation and physiologic parameters in patients weaning from mechanical ventilation</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/8024</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Other design features: Eligible patients will be selected through convenience sampling and will be randomly assigned into 2 groups using permuted block randomization with allocation ratio of 1:1. Random allocation sequence will be determined using a computerized program. Opaque sealed sequentially numbered envelopes from number 1 to 80 will be used for allocation concealment, Randomization description: Eligible patients will be randomly assigned into two groups using permuted block randomization , Random numbers table will be used, Random allocation sequence will be determined using a computerized program.Opaque sealed sequentially numbered envelopes from number 1 to 80 will be used for allocation concealment, Blinding description: patients will be unaware of the groups’assignments.staff nurses
in the ICU and the statistical analyzer will be blind to patients’allocation of the groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients with impaired respiratory function in ICU.</hc_freetext>
      <i_freetext>Intervention 1: The experiment group: Acupressure will be performed in this group. The intervention is performed 20 minutes before weaning of mechanically ventilation by a trained person. This technique will be implemented at 5- acupoints on both sides of the body. The 5- acupoints include Zhongfu (Lu1), Taiyuan (Lu9), Hegu (Li4), Neiguan (Pc6) and Zusanli (St36). This technique will be performed on one side of the body first and then the other side of the body based on the patient's condition. Anxiety, agitation and physiologic parameters are measured before the intervention, immediately after the intervention, under T-piece and 20 min after T-piece. T–piece device is placed on the tracheal tube and a high level of oxygen is given to the patients. In addition to administering oxygen, the device can produce about 5 cm PEEP water and an increase in PaCo2 by providing an exhale-resistant resistor. Intervention 2: In control group, touch will be performed at 5 points except the main points in intervention group, 20 minutes before weaning of mechanical ventilation. Anxiety, agitation, and physiologic parameters will be measured before the intervention, immediately after the intervention, under T-piece and 20 min after T-piece.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Nahid Rejeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahed University, Opposite to Holy Shrine of Imam Khomeini, Tehran-Qom Express way, Tehran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3319118651</zip>
        <telephone>+98 21 5121 3071</telephone>
        <email>nrejeh@yahoo.com</email>
        <affiliation>Shahed University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Nahid Rejeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahed University, Opposite to Holy Shrine of Imam Khomeini, Tehran-Qom Express way Tehran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3319118651</zip>
        <telephone>+98 21 5121 3071</telephone>
        <email>nrejeh@yahoo.com</email>
        <affiliation>Shahed University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Four score ≥ 9
Richmond score from +2 to -2
PaO2 ≥ 60 mmHg ، ABG: FiO2 ≤ 40%، PaO2 ≥ 60 mmHg, 25≥ RR)
age over 18
being intubated during past 48 hours
being on ventilation with SIMV and PSV mode
Hemoglobin ≥ 8 mg/dl 
Absence of malformation or grazes in pressure points
Absence of psychiatric illness
Absence of neuromuscular illness 
Absence of active heart disease
Absence of neurologic disorder that affects respiratory
not taking any psychiatric agent 
not taking any neuromuscular blocker agent
not taking sedative during past 4 hours
absence of coagulation disturbance (PTT≤60)</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Exclusion criteria :Patient with no cooperation to end of study ; Weaning of mechanical ventilation ; Death of patient during the study ; Daley of weaning process.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J95 , J96 </hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other diseases of the respiratory system</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The experiment group: Acupressure will be performed in this group. The intervention is performed 20 minutes before weaning of mechanically ventilation by a trained person. This technique will be implemented at 5- acupoints on both sides of the body. The 5- acupoints include Zhongfu (Lu1), Taiyuan (Lu9), Hegu (Li4), Neiguan (Pc6) and Zusanli (St36). This technique will be performed on one side of the body first and then the other side of the body based on the patient's condition. Anxiety, agitation and physiologic parameters are measured before the intervention, immediately after the intervention, under T-piece and 20 min after T-piece. T–piece device is placed on the tracheal tube and a high level of oxygen is given to the patients. In addition to administering oxygen, the device can produce about 5 cm PEEP water and an increase in PaCo2 by providing an exhale-resistant resistor.</i_keyword>
      <i_keyword>In control group, touch will be performed at 5 points except the main points in intervention group, 20 minutes before weaning of mechanical ventilation. Anxiety, agitation, and physiologic parameters will be measured before the intervention, immediately after the intervention, under T-piece and 20 min after T-piece.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety. Timepoint: before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: by Faces anxiety scale.</prim_outcome>
      <prim_outcome>Agitation. Timepoint: before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Richmond Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Heart rate. Timepoint: Before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Monitoring system.</sec_outcome>
      <sec_outcome>Respiratory rate. Timepoint: Before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Ventilator system.</sec_outcome>
      <sec_outcome>Oxygen saturation of arterial blood ( SPo2 ). Timepoint: Before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Pulsoximeter.</sec_outcome>
      <sec_outcome>Heart rate. Timepoint: Before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Monitoring system.</sec_outcome>
      <sec_outcome>Systolic Blood pressure. Timepoint: Before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Monitoring system.</sec_outcome>
      <sec_outcome>Diastolic blood pressure. Timepoint: Before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Monitoring system.</sec_outcome>
      <sec_outcome>Mean blood pressure. Timepoint: Before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Monitoring system.</sec_outcome>
      <sec_outcome>Tidal Volume. Timepoint: Before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Monitoring system.</sec_outcome>
      <sec_outcome>Minute Ventilation. Timepoint: Before intervention, immediately after intervention, under T-Piece, 20 min after T-Piece. Method of measurement: Monitoring system.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research, Shahed University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-11-06</approval_date>
        <contact_name>Ethics committee of Shahed University</contact_name>
        <contact_address>Shahed University, Opposite the Holy Shrine of Imam Khomeini, Tehran-Qom Freeway, Tehran. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
